2Ihn H.The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma.Arch Immunol,Thre Exp.(Warsz),2002,50:325. 被引量：1
3Ozbilgin MK,Inan S.The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma.Clin Rheumatol,2003,22:189～195. 被引量：1
4Mori Y,Chen SJ,Varga J,et al.Expression and regulation of intracellular SMAD Signaling in scleroderma Skin fibroblasts.Arthritis Rheum,2003,48:1964～1 978. 被引量：1
5Sato M,Shegogue D,Gore EA,et al.Role of P38 MAPK in transforming growth factor-beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.J Invest Dermatol,2002,118:704. 被引量：1
6Leask A,Holmes A,Black CM,et al.Connective tissue growthfactor gene regulation requirements for its induction by transforming growth factor-beta 2 in fibroblasts.J Biol Chem,2003,278(15):130085. 被引量：1
7Leask A,Holmes A,Abraham DJ,Connective tissue growth factor:a new and important player in the pathogenesis of fibrosis.Curr Rheumatol Rep,2002,4:136～142. 被引量：1
8Distler O,Pap T,Kowal-Bielecka O,et al.Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis:role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.Arthritis Rheum,2001,44:2 665～2 678. 被引量：1
10Sato S,Hasegawa M,Takehara k.Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.J Dermatol Sci,2001,27:140～146. 被引量：1
二级参考文献46
1Riccieri V, Rinaldi T, Spadaro A, et al. Interleukin - 13 in systemic sclerosis: relationship to nailfold capillaroseopy abnormalities. Clin Rheumatol, 2003,22 : 102 - 106. 被引量：1
2Kurasawa K, Hirose K, Sano H, et al. Increased interleukin - 17 production in patients with systemic sclerosis. Arthritis Rheum,2000,43 :2455 - 2463. 被引量：1
3Choi JJ, Min DJ, Cho ML,et al. Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol, 2003,30:1529 - 1533. 被引量：1
4Distler O, Del Rosso A, Giacomelli R,et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res, 2002,4 :R11. 被引量：1
5Tsuji-Yamada J, Nakazawa M, Minami M, et al. Increased frequency of interleukin 4 producing CD4 + and CD8 + ceils in peripheral blood from patients with systemic sclerosis. J Rheumatol,2001,28:12528. 被引量：1
6Neiko IeM, Iatsyshyn RI. Role of interleukin - 1 and interleukin - 2 in the pathogenesis of systemic scleroderma. Fiziol Zh, 2002,48:56 -61. 被引量：1
7Yamamoto T, Eckes B, Krieg T. High expression and autoinduction of monocyte chemoattractant protein - 1 in scleroderma fibroblasts. Eur J Immunol, 2001,31:2936 -2941. 被引量：1
8Distler O, Pap T, Kowal-Bielecka O, et al. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet -derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum,2001 ,44:2665 - 2678. 被引量：1
9Postiglione L, Montagnani S, Riccio A, et al. Enhanced expression of the receptor for granulocyte macrophage colony stimulating factor on dermal fibroblasts from scleroderma patients. J Rheumatol, 2002,29:94 - 101. 被引量：1
10Ihn H. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma. Arch Immunol Ther Exp (Warsz), 2002,50:325. 被引量：1
